31417-69-3 Usage
Uses
Used in Pharmaceutical Synthesis:
1-(4-(Aminomethyl)phenyl)-N-methylmethanamine is used as a key intermediate in the synthesis of various pharmaceutical products for [application reason] its ability to be incorporated into the molecular structures of medications, enhancing their therapeutic properties and effectiveness.
Used in Agrochemical Production:
In the agrochemical industry, 1-(4-(Aminomethyl)phenyl)-N-methylmethanamine is used as a vital component in the development of [application type] for [application reason] its potential to contribute to the creation of effective and targeted agrochemicals, addressing various agricultural needs.
Used in Medicinal Chemistry Research and Development:
1-(4-(Aminomethyl)phenyl)-N-methylmethanamine is employed as a valuable compound in the field of medicinal chemistry research and development, where it is used as [application type] for [application reason] its potential to facilitate the discovery and design of innovative pharmaceutical compounds with improved therapeutic profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 31417-69-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,1,4,1 and 7 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 31417-69:
(7*3)+(6*1)+(5*4)+(4*1)+(3*7)+(2*6)+(1*9)=93
93 % 10 = 3
So 31417-69-3 is a valid CAS Registry Number.
31417-69-3Relevant academic research and scientific papers
Boronic acid based photoinduced electron transfer (PET) fluorescence sensors for saccharides
Larkin, Joseph D.,Frimat, Karine A.,Fyles, Thomas M.,Flower, Stephen E.,James, Tony D.
, p. 2922 - 2931 (2011/02/27)
A simple three step synthesis was developed to provide six novel modular sensors, consisting of three para sensors, and three meta sensors with naphthalene, anthracene and pyrene fluorophores. The interaction of the six sensors with the saccharides: d-glu
COMPOSITIONS AND METHODS FOR TREATING MAST-CELL MEDIATED CONDITIONS
-
, (2008/06/13)
The present invention describes compounds, methods and compositions effective to treat mast cell mediated inflammatory conditions, such as conjunctivitis, asthma and allergic rhinitis. The compounds of the invention comprise novel mono-and di-aminomethylb
